Suda Pharmaceuticals Ltd Share Price Australian S.E.
Equities
SUD
AU0000063661
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% | -.--% | -.--% |
03-26 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
03-20 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
Sales 2022 | 296K 192K 15.34M | Sales 2023 | 1.45M 945K 75.44M | Capitalization | 42.5M 27.6M 2.2B |
---|---|---|---|---|---|
Net income 2022 | -8M -5.19M -415M | Net income 2023 | -10M -6.49M -519M | EV / Sales 2022 | 32 x |
Net cash position 2022 | 5.93M 3.85M 307M | Net cash position 2023 | 5.18M 3.36M 268M | EV / Sales 2023 | 25.7 x |
P/E ratio 2022 |
-1.47
x | P/E ratio 2023 |
-3.49
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.45% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Baker
CEO | Chief Executive Officer | - | 01/01/20 |
Tim Luscombe
DFI | Director of Finance/CFO | - | 11-30 |
Michelle Long
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 62 | 30/06/22 |
Elizabeth Stoner
BRD | Director/Board Member | 73 | 09/11/21 |
Thomas Duthy
CHM | Chairman | - | 12/03/23 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.40% | 42.86B | |
+13.42% | 42.74B | |
+44.87% | 41.36B | |
-8.83% | 27.68B | |
+7.12% | 25.15B | |
-23.33% | 18.63B | |
+29.77% | 12.37B | |
-2.72% | 11.92B | |
+7.33% | 11.21B |
- Stock Market
- Equities
- ALA Stock
- SUD Stock